55th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

On April 6, 2018, the 55th of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans. Taking place at the Scottsdale Research Institute (SRI) in Phoenix, Arizona, this clinical trial will evaluate the safety and efficacy of four different potencies of marijuana for symptoms of PTSD in 76 U.S. veterans. On March 26 – 29, Gabby Fortier, Clinical Research Associate, monitored the clinical research site. A new recruitment website can be visited here. Learn more… | Visit the Recruitment Website